Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

FDA fast track designation for Biogen’s investigational Alzheimer’s treatment

September 2, 2016 Medical Communications, Research and Development Alzheimer's, Alzheimer’s, Biogen, FDA, aducanumab, fast track

Biogen has announced that its investigational Alzheimer’s disease treatment aducanumab has been granted fast track designation by the FDA. The …
News
amgen_flag

Amgen’s leukaemia treatment given FDA thumbs up for use in paediatric patients

September 2, 2016 Medical Communications, Sales and Marketing Amgen, FDA, blincyto, leukaemia

Amgen has announced that the FDA has approved the supplemental Biologics License Application for Blincyto (blinatumomab) in the treatment of …
News

NICE recommends Bayer’s Xofigo for prostate cancer treatment

September 2, 2016 Medical Communications, Sales and Marketing Bayer, NICE, approval, prostate cancer, recommendation, xofigo

NICE has issued final draft guidance recommending Bayer’s Xofigo (radium-223 dichloride) for the treatment of prostate cancer. Previously, the drug …
News
abpi_reception_right

ABPI welcomes Roche back into the fold eight years after suspension

September 1, 2016 Medical Communications, Research and Development ABPI, Roche, rejoin, suspension

Less than a decade after the company was suspended, Roche has now successfully re-joined the Association of the British Pharmaceutical …
News

Sepha is fast packing with a new EZ Blister upgrade.

September 1, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Packaging Equipment Specialist, Sepha, has released a functional upgrade for one of its original products, EZ Blister, the lab scale …
News
Press release
cloud

Cloud on the horizon: Cloud computing and the clinical trial

September 1, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cloud Computing, ICON, clinical trials, ibm

 Originally published in the September edition of Pharmafocus, Matt Fellows investigates how cloud computing may just be the answer the …
Feature

Eli Lilly elects Jamere Jackson to board of directors

September 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

Eli Lilly has elected Jamere Jackson to its board of directors, effective 1 October, where he will serve on the …
Appointment

Recipharm establishes long term supply agreement with Tillotts Pharma AG

August 31, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recipharm, the contract development and manufacturing organisation (CDMO), announces that it has entered into a long term supply agreement with …
News
Press release
pharmafocus_sept_2016_cover

The September issue of Pharmafocus is now live!

August 31, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myer's Squibb, Bristol-Myers Squibb, CDF, Cancer Drugs Fund, Cloud Computing, Pharmafocus, Pharmafocus new issue, brexit, clinical trial transparaency, opdivo

The latest edition of Pharmafocus is available online now. In this issue, we explore the future of the clinical trial …
News
top_ten

Top ten stories in the pharmaceutical industry this week

August 26, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile, top 10

If this week left you feeling with a sense of déjà vu, you could certainly be forgiven. With US politicians …
News
lab

EMA accepts regulatory submission for proposed Herceptin biosimilar

August 26, 2016 Medical Communications Biocon, EMA, Herceptin, Mylan, biosimilar, regulatory, submission, trastuzumab

Mylan and Biocon have announced that the European Medicines Agency (EMA) has accepted for review its marketing authorisation application for …
News
clinical_trial_4

Denali Therapeutics secures another $130 million for neurodegenerative disease research

August 26, 2016 Medical Communications

Denali Therapeutics has announced a string of collaborations and financing deals worth $130 million that will see the biotech, which …
News
takeda_tokyo_hq

Jobs to go at Takeda as it shuts down Cambridge facility

August 26, 2016 Manufacturing and Production, Medical Communications Cambridge, Jobs, Takeda, closure

Takeda has announced plans to close its facility in Cambridge in the UK, to refocus its research and development operations …
News
mylan_building

Mylan announces immediate plans to cut price of EpiPen

August 25, 2016 Medical Communications, Research and Development Mylan, clinton, epipen, increase

Subject to intense pressure over the last few days, Mylan has made an attempt to avoid becoming “another Valeant” by …
News
paul_herendeen

Valeant appoints new executive VP of finance and CFO

August 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Valeant, appointment

Valeant has announced the appointment of Paul S. Herendeen as executive vice president, who will also take over as chief …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025